Want to see UVV full AI Analyst Report?
Operating Income by Segment
Measures operating profit for each segment to show which parts of the business actually generate earnings after costs; exposes margin differences, operational efficiency, and segments that are subsidizing others—critical for forecasting earnings, dividend capacity, and where cost cuts or investment can improve returns.The company’s operating income is overwhelmingly driven by Tobacco—its scale cushions results but is showing earnings volatility tied to seasonal peaks and large inventory write‑downs that eroded Q4/FY26 profits—so performance remains exposed to crop cycles and pricing. Ingredients is no longer a reliable margin contributor: Shanks-related underperformance and a $41M goodwill impairment highlight execution and fixed‑cost pressure, meaning ingredients recovery depends on management’s commercial fixes. 'Other' is a recurring drag from one‑offs. Management’s plan to cut uncommitted inventory and strengthen execution is critical to stabilizing earnings and protecting the dividend.
Date | Other | Tobacco Operations | Ingredients Operations |
|---|---|---|---|
Jun 30, 2026 | -$510.00K | $3.47M | -$660.00K |
Mar 31, 2026 | -$2.30M | $26.58M | $1.82M |
Dec 31, 2025 | -$1.97M | $84.04M | -$126.00K |
Sep 30, 2025 | $2.56M | $65.25M | -$160.00K |
Jun 30, 2025 | -$3.56M | $35.67M | $1.70M |
Mar 31, 2025 | -$7.46M | $45.83M | $4.39M |
Dec 31, 2024 | -$2.15M | $102.57M | $3.66M |
Sep 30, 2024 | -$9.93M | $77.33M | $1.33M |
Jun 30, 2024 | -$140.00K | $14.45M | $2.91M |
Mar 31, 2024 | -$4.25M | $73.48M | -$1.03M |